Brazilian researcher Tatiana Sampaio presented peer-reviewed data indicating significant recovery in paralysis patients through compassionate use of the neural regeneration drug. Speaking at Pier Mauá on Friday, August 7, Brazilian biologist and Federal University of Rio de Janeiro (UFRJ) researcher Tatiana Sampaio shared findings from a novel study on Polylaminin (Polilaminina). “We came to the conclusion that Polylaminin is safe,” Dr. Sampaio stated. Polylaminin, originally developed by Dr. Sampaio in the late 1990s, has long represented a critical avenue of hope for treating severe spinal trauma. “Tatiana Sampaio represents science that reaches people and gives them hope for a better life,” Ms. Roque affirmed.